Mycophenolate Mofetil in Systemic Sclerosis With Subclinical Interstitial Lung Disease

Conditions:   Systemic Sclerosis With Lung Involvement;   Systemic Sclerosis;   Interstitial Lung Disease Interventions:   Drug: Mycophenolate Mofetil;   Other: Placebo Sponsors:   Centre hospitalier de l'Université de Montréal (CHUM);   McGill University;   University of Calgary;   St. Joseph's Healthcare Hamilton;   Jewish General Hospital;   Canadian Institutes of Health Research (CIHR);   Sclérodermie Québec Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials